ABSTRACT
The Anaphase Promoting Complex or Cyclosome (APC/C) is critical to the control of mitosis. The APC/C is an ubiquitin ligase that targets specific mitotic regulators for proteolysis at distinct times in mitosis, but how this is achieved is not well understood. We have addressed this question by determining whether the same substrate, cyclin B1, is recognised in the same way by the APC/C at different times in mitosis. Unexpectedly, we find that distinct but overlapping motifs in cyclin B1 are recognised by the APC/C in metaphase compared with anaphase, and this does not depend on the exchange of Cdc20 for Cdh1. Thus, changes in APC/C substrate specificity in mitosis can potentially be conferred by altering interaction sites in addition to exchanging Cdc20 for Cdh1.
INTRODUCTION
The cell cycle is driven by alternating states of high and low cyclin-dependent kinase activity (Morgan, 2007). Ubiquitin-mediated proteolysis underpins this by destabilising specific cyclins at particular times, which is especially important for the B-type cyclins that drive the cell into mitosis (Murray et al., 1989; Wolf et al., 2006). B-type cyclins are targeted for destruction only when the Spindle Assembly Checkpoint (SAC) is inactivated when all the chromosomes have properly attached to the mitotic spindle (Clute and Pines, 1999). The B-type cyclins continue to be degraded through the next G1 phase until cells have re-licensed chromosomes for the next round of DNA replication (Amon et al., 1994; Brandeis and Hunt, 1996); hence each cell division must normally be followed by a round of DNA replication.
The B-type cyclins are ubiquitylated (Glotzer et al., 1991) by the Anaphase Promoting Complex (King et al., 1995; Yamashita et al., 1996; Zachariae et al., 1996) or Cyclosome (Sudakin et al., 1995) (APC/C), a multi-subunit ubiquitin ligase that recognises a variety of different proteins in mitosis and in G1 phase (reviewed by Barford, 2011; Pines, 2011). The APC/C is able to select different substrates at different times in mitosis (Pines, 2006), but how it does so is still unresolved. In early mitosis the APC/C is activated by the Cdc20 protein that itself is regulated by the SAC (Fang et al., 1998; Hwang et al., 1998; Kim et al., 1998; Sudakin et al., 2001; Yu, 2007). The SAC detects improperly attached chromosomes (Hoyt et al., 1991; Li and Murray, 1991; Murray, 2011; Rieder et al., 1995) and inactivates Cdc20 to prevent the APC/C from recognising securin and cyclin B1, thereby preventing sister chromatid separation and exit from mitosis, respectively. While the SAC is active, however, the APC/C can still recognise some of its other substrates, notably cyclin A (Di Fiore and Pines, 2010; den Elzen and Pines, 2001; Geley et al., 2001; Wolthuis et al., 2008) and Nek2A (Hayes et al., 2006). Only when the SAC is inactivated in metaphase does the APC/C begin to degrade securin and cyclin B1 (Clute and Pines, 1999; Hagting et al., 2002). Part of the explanation for why some substrates, such as cyclin A and Nek2A, are degraded earlier than others in mitosis is because they bind directly to the APC/C (Di Fiore and Pines, 2010; Hayes et al., 2006; Wolthuis et al., 2008). But recruitment alone is not sufficient to confer earlier degradation because neither Kif18A nor cyclin B1 are degraded while the SAC is active despite being bound to the APC/C (Sedgwick et al., 2013; van Zon et al., 2010). Thus, in addition to binding to the APC/C, cyclin A also recruits Cdc20 (Di Fiore and Pines, 2010; Wolthuis et al., 2008), and Nek2A can be degraded in trans when the amino-terminus of Cdc20 or the related protein, Cdh1 are added to activate the APC/C (Kimata et al., 2008).
Once cells begin anaphase the APC/C recognises a wider variety of substrates, including Plk1, the Aurora kinases, and Cdc20 itself (Floyd et al., 2008; Lindon and Pines, 2004; Littlepage and Ruderman, 2002; Pfleger et al., 2001). The anaphase and G1 phase APC/C ubiquitylate a broader range of substrates and a number of APC/C degrons have been identified in addition to the classical ‘Destruction box’ (consensus: RxxLxxI/VxN) that mediates Cyclin B1 and securin destruction (Glotzer et al., 1991; King et al., 1996; Yamano et al., 1998; Zur and Brandeis, 2001) (note that lysine substitutes for arginine in Drosophila securin (Leismann et al., 2000)). These degrons include the KEN box (Pfleger et al., 2001) (consensus: KENxxxN/D), and other motifs such as the O-box (Araki et al., 2003) or the GxEN motif (Castro et al., 2003) that often resemble degenerate D-boxes or KEN-boxes (Barford, 2011). The molecular mechanism behind this change in substrate specificity is partially attributable to the replacement of Cdc20 by Cdh1 (Visintin et al., 1997; Zur and Brandeis, 2002). For example, Aurora A is degraded in anaphase but only in cells with Cdh1 (Floyd et al., 2008; García-Higuera et al., 2008; Sigl et al., 2009), and the D-box of Hsl1 is recognised by APC/C bound to Cdc20 whereas its KEN-box is recognised by APC/C bound to Cdh1 (Burton and Solomon, 2001).
The change in the substrate specificity of the APC/C in anaphase is not, however, as simple as a switch from D-boxes to KEN-boxes when Cdc20 is replaced by Cdh1. For example, both Plk1 and Aurora A are degraded in anaphase but this requires a D-box (Lindon and Pines, 2004; Littlepage and Ruderman, 2002) rather than a KEN box (Littlepage and Ruderman, 2002) (plus an A-box in the case of Aurora A (Littlepage and Ruderman, 2002)). It has been suggested that Plk1 is degraded before Aurora A in anaphase simply because it is a more processive substrate (Rape et al., 2006), but there appears to be a more qualitative difference because Aurora A can only be recognised by the APC/C bound to Cdh1 (Floyd et al., 2008; García-Higuera et al., 2008; Sigl et al., 2009) whereas Plk1 can be degraded in anaphase by the APC/C whether or not Cdh1 is present (Floyd et al., 2008). The importance of the change in APC/C specificity in different phases of the cell cycle is illustrated by the genetic instability of cells lacking Cdh1 (García-Higuera et al., 2008; Sigl et al., 2009), and the observation that perturbing the destruction of late mitotic substrates leads to problems in cytokinesis (Floyd et al., 2008; Lindon and Pines, 2004).
Recent biochemical and structural data indicate that the APC/C recognises some of its substrates through a bi-partite receptor composed of co-activator (Cdc20 or Cdh1) and the APC10 subunit (Buschhorn et al., 2011; Chao et al., 2012; da Fonseca et al., 2011; Izawa and Pines, 2011; Matyskiela and Morgan, 2009; Passmore and Barford, 2005). Exactly how the substrate binds into this receptor is not yet clear, but the interactions between Cdc20 and two checkpoint proteins in the structure of the Mitotic Checkpoint Complex (Chao et al., 2012) indicate that a KEN-box can bind to the top surface of Cdc20. By contrast, the D-box appears to bind to the side of Cdc20, between blades 1 and 7 of the beta-propeller domain (Chao et al., 2012) and to the Doc domain of APC10 (Carroll et al., 2005; da Fonseca et al., 2011; Passmore et al., 2003).
Given the importance of the cell cycle-regulated destruction of the B-type cyclins, we set out to define better how cyclin B1 is recognised by the APC/C through the cell cycle. We have found that the destruction motif that is recognised in metaphase overlaps with, but is distinct from, that recognised in anaphase and G1 phase, and this change is not dependent on replacing Cdc20 with Cdh1. Furthermore, several residues important for destruction are dispensable if Cyclin B1 can be recruited to the APC/C in anaphase, but not in metaphase. We conclude that multiple motifs are required to mediate recognition by the APC/C and these change as cells progress through mitosis. This may contribute to the ability of the APC/C to recognise different proteins at different times in mitosis.
RESULTS
Leucine 45 is the most critical residue in the Cyclin B1 Destruction box
Previous analyses of the residues required for a functional D-box primarily measured protein half-lives and not the point in mitosis that the protein became unstable (Glotzer et al., 1991; King et al., 1996; Yamano et al., 1998). To assay the timing of destruction we set up a live-cell assay in which we linked wild type or mutant human cyclin B1 to a fluorescent protein (CFP or YFP) to enable us to compare their destruction in the same cell (in all cases we checked that the same results were obtained when we swapped the fluorescent tags). To analyse the destruction of proteins in metaphase, protein values were normalised to those at NEBD; to analyse destruction in anaphase data were normalised to the beginning of anaphase. Note that we obtained similar results in assays where we depleted endogenous cyclin B1 by siRNA (directed against the 3′ UTR that is not present in the transgene) to exclude differences in degradation timing caused by competition with the endogenous protein, and that in agreement with previous studies (Wolf et al., 2006), non-degradable cyclin B1 blocked cells in anaphase rather than in metaphase.
We first analysed the effect of mutating those conserved residues of the cyclin B1 D-box that had previously been shown to be most critical for destruction: R42, L45, and N50 (King et al., 1996; Yamano et al., 1998) (Fig. 1A). L45 proved to be essential for degradation in both metaphase and anaphase (Fig. 1B,C). The likely explanation for this is that the structure of the putative D-box binding site on Cdc20 indicated that L45 should be buried in a deep pocket (Chao et al., 2012). By contrast, we found mutating R42, which is commonly used to inactivate a D-box, only partially stabilised Cyclin B1 in anaphase (Fig. 1D,E). Mutating N50 had a similar effect to mutating R42 (Fig. 1F,G), but mutating both residues stabilised cyclin B1 in both metaphase and anaphase, in a similar fashion to mutating L45 (Fig. 1H,I).
L45 of the Cyclin B1 D-box is most important for degradation.
Identifying an Anaphase Degron
Since the APC/C recognises a wider range of substrates in anaphase than in metaphase, we considered the possibility that different residues in cyclin B1 might be important for recognition in anaphase. Deleting the first 40 amino acids (i.e. very close to the start of the original D-box, Fig. 1A) blocked degradation in mitosis altogether (Fig. 2A,B), as previously observed for sea urchin cyclin B and for fission yeast securin/cut2 (King et al., 1996; Yamano et al., 1998). Removing the first 9 amino acids slightly slowed down metaphase degradation, but not anaphase degradation (Fig. 2C,D). An internal deletion from amino acids 11 to 41 also perturbed cyclin B1 degradation in metaphase, and appeared to have an even greater effect in anaphase (Fig. 2E,F).
The first 40 amino acids of cyclin B1 are required for its degradation.
To narrow down the region responsible for promoting anaphase recognition by the APC/C we used an in vitro ubiquitylation system (Enquist-Newman et al., 2008) and found that the Δ11–41 mutant could hardly be ubiquitylated (Fig. 3A,B). We made a series of smaller internal deletions and found that deleting residues 21 to 25 greatly reduced ubiquitylation by APC/C in vitro (Fig. 3A,B). Moreover, this mutant was also stabilised in anaphase in vivo (supplementary material Fig. S1A,B). To refine this analysis we constructed point mutations in each of the residues from positions 21 to 25 and identified M21 as the critical residue for anaphase degradation (Fig. 3C,D). (Positions 22, 23, 24 are A–G–A, and mutating K25 to alanine did not affect degradation, data not shown.) Cells expressing the M21A mutant arrested in anaphase and it was notable that M21 was not required for degradation in metaphase (Fig. 3C).
Residues N-terminal to the canonical D-box of cyclin B1 are required for its ubiquitylation and degradation in anaphase.
What caused this change in APC/C specificity in anaphase? The obvious candidate was the exchange of Cdc20 for Cdh1, but we found there was no difference in the ability of mouse embryonic fibroblasts (MEFs) lacking Cdh1 (García-Higuera et al., 2008) to degrade cyclin B1 in metaphase or anaphase (Fig. 3E,F). Moreover, the requirement for M21 for degradation in anaphase was conserved (supplementary material Fig. S1C,D). We also excluded the possibility that the M21A mutant inhibited the anaphase APC/C because HeLa cells could still degrade the R42A mutant and Plk1 (supplementary material Fig. S1E). By contrast, Aurora A was stabilised as expected because the stabilised Cyclin B1-Cdk1 activity in anaphase prevented the activation of Cdh1 (Floyd et al., 2008). We conclude that the metaphase and anaphase APC/Cs recognise the same substrate in different ways: R42, N50 and particularly L45, are important for a functional D-box in metaphase, whereas in anaphase there is an additional requirement for M21.
Multi-valent recruitment of Cyclin B1 to the APC/C is required for its degradation in metaphase and anaphase
The cyclin B1-Cdk1 complex has previously been shown to bind to the APC/C through its partner Cks1 protein, and this improves the efficiency of its destruction (van Zon et al., 2010). To test whether the difference in D-box residues recognised by metaphase and anaphase APC/Cs was due to a difference in their ability to bind cyclin B1, we recruited wild type or a R42A/L45A double mutant of cyclin B1 directly to the APC/C by fusing its carboxyl terminus to the Cks1 protein (Di Fiore and Pines, 2010; Wolthuis et al., 2008). This revealed a marked difference between metaphase and anaphase cells: recruiting the double mutant to the metaphase APC/C had no effect, but recruiting it to the anaphase APC/C allowed it to be degraded (Fig. 4A,B). These experiments further underlined the importance of M21 to anaphase recognition because mutating M21 partially stabilised this construct in anaphase (Fig. 4A,B). Note that we could not substitute Cks1 with a C-terminal IR motif (Fig. 4C,D); therefore it may be important where and how the C-terminus of cyclin B1 binds to the APC/C.
The N-terminus of Cdc20 can substitute for a D-box when cyclin B1 is targeted to the APC/C by Cks1.
Our results also indicated that APC/C appeared to have a more stringent requirement for the canonical D-box to recognise its substrates in metaphase than in anaphase. Therefore, we asked whether we could substitute the D-box of cyclin B1 with another APC/C-binding motif to confer metaphase destruction. We selected the N-terminus of Cdc20, which directed the degradation of Mes1 (Kimata et al., 2008). Kimata et al. found that the N-terminus of Cdc20 could not direct the degradation of cyclin B (Kimata et al., 2008), and we confirmed this result when we fused the N-terminus of Cdc20 to the R42A/L45A double mutant of cyclin B1 (Fig. 4E,F). Kimata et al. also showed that the N-terminus of Cdc20 could direct the destruction of Nek2A in trans. Nek2A differs from cyclin B1 in that it can bind directly to the APC/C through its IR tail; therefore, we tested whether binding cyclin B1 to the APC/C through Cks1 would now allow the N-terminus of Cdc20 to substitute for a D-box, and found that it did (Fig. 4E,F). Furthermore, this degradation did not require the KEN box (Fig. 4G,H) but did require the C-box and the KILR motif (Fig. 4G,H), the two known APC/C-binding motifs in the N-terminus of Cdc20. Similarly, a non-phosphorylatable version of the N-terminus of Cdh1 was also able to direct degradation of the R42A/L45A mutant fused to Cks1 (Fig. 4I,J), and was noticeably more potent in metaphase, but not anaphase, when we mutated its KILR motif to mimic that in Cdc20 (Fig. 4I–K).
DISCUSSION
In this study we have investigated how the APC/C recognises its different substrates at different times by asking whether the key mitotic substrate, cyclin B1, is recognised in the same way in different mitotic phases. Cyclin B1 is first recognised in metaphase when the SAC is inactivated (Clute and Pines, 1999) but continues to be degraded in anaphase because cells enter anaphase with substantial amounts of cyclin B1 remaining (Collin et al., 2013). It is essential to degrade the remaining cyclin B1 for cells to undergo cytokinesis and exit mitosis (Wolf et al., 2006), and thus cells expressing the M21A mutant arrest in anaphase. We were surprised to find that the APC/C recognises overlapping but distinct motifs on cyclin B1 depending on whether it was in metaphase or anaphase: in metaphase the canonical D-box is most important, whereas in anaphase an additional region 20 amino acids N-terminal to the D-box is also important. In particular we identified M21 as crucial for anaphase degradation, and this residue is conserved in mammalian B1 cyclins but not in other vertebrates. Furthermore, the M21 region is important in anaphase cells that lack the Cdh1 co-activator protein, indicating that the change in APC/C substrate recognition must involve processes other than simply exchanging Cdc20 for Cdh1. We interpret these results as showing that the substrate interaction surfaces on the APC/C differ in a cell cycle-dependent manner.
At present we do not have a molecular mechanism for what causes the change in substrate recognition. Aside from the exchange of Cdc20 for Cdh1, the most prominent change in an anaphase cell compared to a metaphase cells is the change in the balance of protein kinases and phosphatases that is required for cytokinesis (Cundell et al., 2013); therefore, there may be a change in the phosphorylation state of substrate interaction motifs on the APC/C, although we find that any change does not require the inactivation of cyclin B1-cdk1. Alternatively, the region around M21 might be important for other aspects of APC/C-dependent ubiquitylation such as the addition of ubiquitin chains, or the pattern of the added chains that could alter the affinity for the proteasome. It is also conceivable that the change in substrate recognition is due to a change in the E2 used in anaphase, and indeed we previously found that UbcH10 begins to be degraded in anaphase (Walker et al., 2008).
The difference in the importance of the D-box for recognition by the APC/C in metaphase and anaphase is also illustrated by our finding that it can be dispensed with completely in anaphase if a substrate is recruited directly to the APC/C through the Cks1 protein, which binds to phosphorylated APC/C (Rudner and Murray, 2000). By comparison, this is not sufficient to degrade a substrate in metaphase. Both biochemical and structural data (Carroll et al., 2005; da Fonseca et al., 2011; Kraft et al., 2005; Passmore and Barford, 2005) indicate that the D-box is recognised by a bi-partite receptor composed of the co-activator and the APC10 subunit, but our data indicate that there may be differences between the metaphase and anaphase APC/Cs in substrate recognition surfaces outside this receptor.
We are able to destabilise cyclin B1 in metaphase when we recruit it to the APC/C through Cks1 and replace its D-box with another APC/C binding motif: the N-terminus of Cdc20. This adds to the accumulating evidence that substrate binding to the APC/C requires the cooperation of multiple interaction motifs (Burton and Solomon, 2001; Hames et al., 2001; Sedgwick et al., 2013; Wolthuis et al., 2008). Binding through multiple cooperating motifs rather than one high affinity interaction site would offer the opportunity for the APC/C to evolve interaction surfaces to favour the recognition of multiple substrates at different times in the cell cycle.
MATERIALS AND METHODS
Cell culture and synchronization
HeLa cells were cultured in Advanced DMEM (Life Technologies Ltd, Paisley, UK) supplemented with 2% foetal bovine serum, glutamax-I (200 µM), penicillin (100 U/ml), streptomycin (100 µg/ml) and fungizone (250 ng/ml) at 37°C, 10% CO2. MEFs were cultured in the medium previously described (García-Higuera et al., 2008). HeLa cells were synchronised at G1/S transition by a thymidine/aphidicolin block: the day after seeding, cells were blocked with thymidine (2.5 mM, Sigma–Aldrich, Gillingham, UK) for 24 hours, released for 12 hours and then blocked again with aphidicolin (2.5 µg/ml, Sigma–Aldrich) for 24 hours. Cells were then released in fresh DMEM.
Microinjection and time-lapse imaging and analysis
For microinjection and microscopy, the cells were grown on a Bioptechs ΔT heating stage (Bioptechs, Butler, PA) attached to a Leica DMIRBE microscope and the culture medium was replaced with Leibovitz's L-15 medium (Life Technologies Ltd) supplemented with 10% foetal bovine serum, penicillin (100 U/ml) and streptomycin (100 µg/ml). Cells were microinjected with cDNA encoding cyclin B1-Venus at a concentration of 3 ng/µl in G2 cells, using a semiautomatic microinjector (Eppendorf, Stevenage, UK) on a Leica DMIRBE microscope (Leica Microsystems, Milton Keynes, UK) and assayed by time-lapse DIC and fluorescence microscopy as previously described (Karlsson and Pines, 1998). Parameters used for all images captured were exposure time 200 mseconds, 40× oil objective lens with a numerical aperture of 1.2. All images were captured at 3 minutes intervals and analyzed by SlideBook software (Intelligent Imaging Innovations, Denver, CO, USA).
Ubiquitylation assay
E1, E2, Cdh1, and APC/C were expressed and purified as described previously (Carroll et al., 2005; Enquist-Newman et al., 2008). Substrates were transcribed and translated in vitro using the TNT system (Promega, Madison, WI) from plasmids with 35S-methionine and treated with 10 mM NEM (10 minutes) followed by 20 mM DTT (10 minutes) to inactivate ubiquitin chain-extending activities in the reticulocyte lysate. E1 (Uba1, 300 nM), E2 (Ubc4, 50 µM), ubiquitin (150 µM), and ATP (1 mM) were incubated for 15 minutes. APC/C (0.1–1 nM), substrate (2 µl of TnT mix into 15 µl reaction), and Cdh1 (2 µl of TnT mix into 15 µl reaction) were added. Reaction were incubated for the indicated times at room temperature, stopped by the addition of SDS sample buffer, separated by SDS-PAGE, and visualized and quantified with a Molecular Dynamics Phosphorimager (GE Healthcare, Fairfield, CT).
Acknowledgements
We are grateful to Drs Sergio Moreno and Marcos Malumbres for the gift of Cdh1−/− MEFs. We thank all the members of our laboratory for critical insights and discussions.
Funding
This work was supported by a Programme grant from CR UK to JP. JP acknowledges core funding provided by the Wellcome Trust (092096) and CRUK (C6946/A14492).
References
Competing interests
The authors declare no conflict of interest.